EVALUATION OF ANTIINFLAMATORY ACTIVITY OF BUDDLEJA DAVIDII

  • Unique Paper ID: 190843
  • Volume: 12
  • Issue: 8
  • PageNo: 5203-5214
  • Abstract:
  • Objective: The present study aimed to evaluate the anti-inflammatory activity of Buddleja davidii extract using various acute and chronic inflammation models in rats. Methods: The anti-inflammatory potential of Buddleja davidii was assessed at two doses (400 mg/kg and 600 mg/kg) using carrageenan, histamine, dextran, serotonin, and formaldehyde-induced paw oedema models, as well as the cotton pellet-induced granuloma model. Diclofenac sodium (10 mg/kg) served as the standard drug. Biochemical parameters, including total protein, albumin, acid phosphatase (ACP), and alkaline phosphatase (ALP), were also measured. Results: Buddleja davidii significantly reduced paw edema in all models, indicating both early- and late-phase anti-inflammatory activity. The higher dose (600 mg/kg) consistently showed greater efficacy, often comparable to Diclofenac. The extract also demonstrated a marked reduction in granuloma weight in the cotton pellet model, indicating activity against chronic inflammation. Biochemical analysis revealed improved protein levels and reduced ALP activity, suggesting hepatoprotective potential. Conclusion: The findings suggest that Buddleja davidii possesses broad-spectrum anti-inflammatory properties, acting through multiple mechanisms. These results support its traditional medicinal use and highlight its potential as a natural therapeutic agent for treating both acute and chronic inflammatory conditions.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{190843,
        author = {P. UDAYA CHANDRIKA and KURVA BHAVANI and P. SOBITHA RANI and AV. KISHORE BABU},
        title = {EVALUATION OF ANTIINFLAMATORY ACTIVITY OF BUDDLEJA DAVIDII},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {8},
        pages = {5203-5214},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=190843},
        abstract = {Objective: The present study aimed to evaluate the anti-inflammatory activity of Buddleja davidii extract using various acute and chronic inflammation models in rats.
Methods: The anti-inflammatory potential of Buddleja davidii was assessed at two doses (400 mg/kg and 600 mg/kg) using carrageenan, histamine, dextran, serotonin, and formaldehyde-induced paw oedema models, as well as the cotton pellet-induced granuloma model. Diclofenac sodium (10 mg/kg) served as the standard drug. Biochemical parameters, including total protein, albumin, acid phosphatase (ACP), and alkaline phosphatase (ALP), were also measured.
Results: Buddleja davidii significantly reduced paw edema in all models, indicating both early- and late-phase anti-inflammatory activity. The higher dose (600 mg/kg) consistently showed greater efficacy, often comparable to Diclofenac. The extract also demonstrated a marked reduction in granuloma weight in the cotton pellet model, indicating activity against chronic inflammation. Biochemical analysis revealed improved protein levels and reduced ALP activity, suggesting hepatoprotective potential.
Conclusion: The findings suggest that Buddleja davidii possesses broad-spectrum anti-inflammatory properties, acting through multiple mechanisms. These results support its traditional medicinal use and highlight its potential as a natural therapeutic agent for treating both acute and chronic inflammatory conditions.},
        keywords = {Buddleja davidii, anti-inflammatory, ALP activity, Paw edema.},
        month = {January},
        }

Cite This Article

CHANDRIKA, P. U., & BHAVANI, K., & RANI, P. S., & BABU, A. K. (2026). EVALUATION OF ANTIINFLAMATORY ACTIVITY OF BUDDLEJA DAVIDII. International Journal of Innovative Research in Technology (IJIRT), 12(8), 5203–5214.

Related Articles